Table 3.

Multivariate linear regression analysis of the association between MAR and NFS, CT_L−S.

Variable	Model 1		Model 2		Model 3
	β	P	β	P	β	P
NFS	0.142	< 0.001	0.106	< 0.001	0.086	0.008
CTL−S	− 0.324	< 0.001	− 0.278	< 0.001	− 0.222	< 0.001

Model 1: adjustment for age, gender, diabetic duration, and drinking.

Model 2: further adjustment for waist circumference, body mass index, systolic blood pressure, diastolic blood pressure, hemoglobin A1c, triglycerides, high-density lipoprotein, homeostasis model assessment of insulin resistance, and uric acid based on Model 1.

Model 3: additional adjustment for alanine aminotransferase and aspartate aminotransferase, as well as the usage of hypoglycemic agents like metformin, thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, and glucagon-like peptide-1 receptor agonists based on Model 2.

MAR Monocyte to apolipoprotein A1 ratio, NFS Nonalcoholic fatty liver disease fibrosis score.